Tissue origin : Cortico-cancellous heterologous bone mix
Tissue collagen : Preserved plus an additional 40% collagen gel
Physical form : Collagen gel type I and III loaded with 60% bone mix
Composition : 60% granulated mix, 40% collagen gel
Granulometry : Up to 300 µm
Re-entry time : About 4 months
Packaging : Syringe: 0.5 cc, 3x0.5 cc
Product codes : 05GEL40S | 1 Syringe | 0.5 cc | Porcine 05GEL40E | 1 Syringe | 0.5 cc | Equine 15GEL40S | 3 Syringes | 3x0.5 cc | Porcine 15GEL40E | 3 Syringes | 3x0.5 cc | Equine
GMDN code : 46425
Gel 40 is made of a collagen matrix (type I and III) obtained using exclusive Tecnoss® process, loaded for 60% of its volume with micronized heterologous bone (granulometry up to 300 µm). The product is in a gel state at temperatures below 30° C; at higher temperatures the viscosity is reduced and Gel 40 can be mixed with hydrosoluble and/or liposoluble drugs. Thanks to its collagen component, Gel 40 facilitates the formation of primary blood clot and the subsequent invasion of repairing and regenerative cells; moreover the cortico-cancellous component provides the necessary scaffold function. The collagen gel component contained in Gel 40 is rapidly and totally resorbed; it is also endowed with exceptional anti-inflammatory, eutrophic and cicatrizing properties. This lipophilia is due mainly to a percentage of polyunsaturated fatty acids of the oleic-linoleic series (to which Omega 3 also belongs) directly derived from the raw material. Such components possess a valuable antioxidant action on the free radicals and therefore aid tissue regeneration.
The distinctive characteristics of viscosity and density of Gel 40 facilitate the handling of the product by the operator, providing a glue-like support. If viscosity is excessive, add a few drops of sterile lukewarm saline and then re-mix thoroughly to obtain the desired density. Placed on site Gel 40 combines with blood, contributing to the fast and compact formation of primary blood clot.
The exclusive Tecnoss® manufacturing process guarantees an exceptional malleability and plasticity: furthermore the syringe packaging provides Gel 40 extraordinary handling properties making this product the ideal choice for crestal access sinus lift1,2, deep and narrow peri-implant defects3, three-wall intrabony defects and, in combination with Evolution membranes, for gingival recessions4. Thanks to the collagen component, Gel 40 facilitates blood clotting and the subsequent invasion of repairing and regenerative cells. Furthermore, the Tecnoss® manufacturing process avoids granules ceramization, allowing a progressive resorption of the biomaterial and, at the same time, a significant new-bone formation rate5. Gel 40 "soft" consistency also guarantees an easy and healthy soft-tissues healing.
1 BARONE A, CORNELINI R, CIAGLIA R, COVANI U IMPLANT PLACEMENT IN FRESH EXTRACTION SOCKETS AND SIMULTANEOUS OSTEOTOME SINUS FLOOR ELEVATION: A CASE SERIES INT J PERIODONTICS RESTORATIVE DENT, 2008 JUN; 28(3):283-9
2 SANTAGATA M, GUARINIELLO L, RAUSO R, TARTARO G IMMEDIATE LOADING OF DENTAL IMPLANT AFTER SINUS FLOOR ELEVATION WITH OSTEOTOME TECHNIQUE: A CLINICAL REPORT AND PRELIMINARY RADIOGRAPHIC RESULTS J ORAL IMPLANTOL, 2010 DEC; 36(6):485-489
3 COVANI U, CORNELINI R, BARONE A BUCCAL BONE AUGMENTATION AROUND IMMEDIATE IMPLANTS WITH AND WITHOUT FLAP ELEVATION: A MODIFIED APPROACH INT J ORAL MAXILLOFAC IMPLANTS, 2008 SEP-OCT; 23(5):841-6
1 CARDAROPOLI D, CARDAROPOLI G HEALING OF GINGIVAL RECESSIONS USING A COLLAGEN MEMBRANE WITH A DEMINERALIZED XENOGRAFT: A RANDOMIZED CONTROLLED CLINICAL TRIAL INT J PERIODONTICS RESTORATIVE DENT, 2009 FEB;29(1):59-67
5 NANNMARK U, AZARMEHR I SHORT COMMUNICATION: COLLAGENATED CORTICOCANCELLOUS PORCINE BONE GRAFTS. A STUDY IN RABBIT MAXILLARY DEFECTS CLIN IMPLANT DENT RELAT RES, 2010 JUN 1; 12(2):161-3